Delfi Diagnostics: Jacob Van Naarden
Jun 22, 2022
Delfi Diagnostics has appointed Jacob Van Naarden to its board of directors. Van Naarden is senior VP of Eli Lilly and CEO of [email protected] He previously served as chief operating officer at Loxo Oncology, which Lilly acquired in 2019. He also previously held positions at HealthCor Management, Aisling Capital, and Goldman Sachs.